Repurposing Existing Drugs to Prevent Dementia
Quick Facts
Why are researchers looking at existing drugs for dementia prevention?
Developing a new neurological drug is slow, costly, and has a high failure rate, and Alzheimer's disease has been especially difficult. Repurposing, which means testing an approved medicine for a new purpose, offers a shortcut because dosing, side effects, and manufacturing are already understood. Health-care databases covering millions of patients allow researchers to look for unexpected associations between a medication and later dementia diagnosis.
A recent analysis reported by ScienceDaily, covering more than 120,000 older adults, suggested that people using common osteoporosis drugs had up to 24% lower risk of Alzheimer's disease and other dementias. Such signals are valuable for generating hypotheses. Proposed explanations include effects on inflammation, vascular health, or bone-derived signaling that influences the brain, but these remain hypotheses rather than established mechanisms.
Why can't observational studies prove a drug prevents dementia?
Observational studies are vulnerable to confounding, where health, income, education, activity level, or access to care influence both who gets a medication and who develops dementia. The healthy user effect is a related problem: people who follow preventive treatment may be generally more health-conscious. Reverse causation also matters, because dementia develops over many years before diagnosis, and early cognitive changes can affect whether someone is prescribed or continues a drug. Researchers use statistical methods to reduce these biases, but cannot eliminate them.
Randomized controlled trials are the way to test cause and effect, since random assignment balances known and unknown factors between groups. For dementia prevention these trials are demanding, often requiring thousands of participants followed for years. Until such evidence exists, patients should not start or change a medication to protect their memory, and should discuss bone health, brain health, and drug choices with their clinician.
What does current evidence say about preventing dementia?
The 2024 Lancet Commission on dementia prevention, intervention, and care identified 14 modifiable risk factors and estimated that addressing them could potentially prevent or delay roughly 45% of dementia cases worldwide. These factors include hearing loss, high LDL cholesterol, hypertension, physical inactivity, smoking, diabetes, obesity, depression, social isolation, and vision loss, among others.
Drug repurposing research should be viewed as complementary to these measures. If a trial eventually confirms a benefit for an existing drug, it could add a practical option for people at risk. For now, controlling blood pressure, staying active, treating hearing loss, and avoiding smoking have the firmest evidence behind them.
Frequently Asked Questions
Not proven. Observational data suggest an association with lower dementia risk, but randomized trials are needed to show that the drugs themselves reduce risk.
No. Medicines should be used for their approved indications under medical supervision. Discuss any questions about brain health with your doctor.
Evidence supports controlling blood pressure and cholesterol, staying physically active, not smoking, treating hearing loss, and staying socially and mentally engaged.
References
- ScienceDaily. Common osteoporosis drugs linked to 24% lower dementia risk in major study.
- Livingston G, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024.